Helland A - Search Results

1

p53 polymorphism and risk of cervical cancer.

Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL. Helland A, et al. Nature. 1998 Dec 10;396(6711):530-1; author reply 532. doi: 10.1038/25034. Nature. 1998. PMID: 9859987 No abstract available.

2

Microsatellite instability in cervical and endometrial carcinomas.

Helland A, Børresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, de la Chapelle A, Lothe RA. Helland A, et al. Int J Cancer. 1997 Mar 4;70(5):499-501. doi: 10.1002/(sici)1097-0215(19970304)70:5<499::aid-ijc1>3.0.co;2-t. Int J Cancer. 1997. PMID: 9052745

3

An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102-DQB1*0602 haplotype: a population-based case-control study of Norwegian women.

Helland A, Olsen AO, Gjøen K, Akselsen HE, Sauer T, Magnus P, Børresen-Dale AL, Rønningen KS. Helland A, et al. Int J Cancer. 1998 Mar 30;76(1):19-24. doi: 10.1002/(sici)1097-0215(19980330)76:1<19::aid-ijc4>3.0.co;2-0. Int J Cancer. 1998. PMID: 9533756

4

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale Al. Helland A, et al. Br J Cancer. 1998 Jul;78(1):69-72. doi: 10.1038/bjc.1998.444. Br J Cancer. 1998. PMID: 9662253 Free PMC article.

5

Allelic imbalance at chromosome region 11q23 in cervical carcinomas.

Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL. Skomedal H, et al. Among authors: helland a. Eur J Cancer. 1999 Apr;35(4):659-63. doi: 10.1016/s0959-8049(98)00413-4. Eur J Cancer. 1999. PMID: 10492643

6

p53 polymorphism and cervical cancer.

Helland A, Børresen-Dale AL. Helland A, et al. Lancet. 1999 Oct 30;354(9189):1561-2. doi: 10.1016/S0140-6736(05)76596-X. Lancet. 1999. PMID: 10551531 No abstract available.

7

Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.

Helland A, Kraggerud SM, Kristensen GB, Holm R, Abeler VM, Huebner K, Borresen-Dale AL, Lothe RA. Helland A, et al. Int J Cancer. 2000 Oct 15;88(2):217-22. doi: 10.1002/1097-0215(20001015)88:2<217::aid-ijc11>3.0.co;2-i. Int J Cancer. 2000. PMID: 11004671

8

Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.

Dai H, Holm R, Kristensen GB, Abeler VM, Børresen-Dale AL, Helland A. Dai H, et al. Among authors: helland a. Anal Cell Pathol. 2001;23(2):45-9. doi: 10.1155/2001/521873. Anal Cell Pathol. 2001. PMID: 11904459 Free PMC article.

9

X chromosome inactivation in cervical cancer patients.

Kristiansen M, Helland A, Kristensen GB, Olsen AO, Lønning PE, Børresen-Dale AL, Ørstavik KH. Kristiansen M, et al. Among authors: helland a. Cancer Genet Cytogenet. 2003 Oct 1;146(1):73-6. doi: 10.1016/s0165-4608(03)00152-3. Cancer Genet Cytogenet. 2003. PMID: 14499700

10

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.

Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. Wang Y, et al. Among authors: helland a. Br J Cancer. 2004 Feb 9;90(3):678-85. doi: 10.1038/sj.bjc.6601537. Br J Cancer. 2004. PMID: 14760384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters